Why CVS Caremark (CVS) Stock Is Gaining Today

NEW YORK (TheStreet) -- CVS Caremark (CVS) was gaining 1.1% to $78.24 Monday after beating analysts' estimates for earnings and revenue in the second quarter.

The drug store operator reported earnings of $1.13 a share for the second quarter, beating the Capital IQ Consensus Estimate of $1.10 a share by 3 cents. Revenue grew 10.7% from the year-ago quarter to $34.6 billion. Analysts expected revenue of $33.47 billion for the quarter.

CVS raised its earnings forecast for the full-year 2014 to between $4.43 and $4.51, up from its previous guidance of $4.36 to $4.50 a share. Analysts expect earnings of $4.46 a share for the year.

Must read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates CVS CAREMARK CORP as a Buy with a ratings score of A+. TheStreet Ratings Team has this to say about their recommendation:

"We rate CVS CAREMARK CORP (CVS) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins."

CVS ChartCVS data by YCharts

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends